Objective-The IκB kinase (IKK) is an enzyme complex that initiates the nuclear factor κB transcription factor cascade, which is important in regulating multiple cellular responses. IKKα is directly associated with 2 major prosurvival pathways, PI3K/ Akt and nuclear factor κB, but its role in cell survival is not clear. Macrophages play critical roles in the pathogenesis of atherosclerosis, yet the impact of IKKα signaling on macrophage survival and atherogenesis remains unclear. Approach and Results-Here, we demonstrate that genetic IKKα deficiency, as well as pharmacological inhibition of IKK, in mouse macrophages significantly reduces Akt S 473 phosphorylation, which is accompanied by suppression of mTOR complex 2 signaling. Moreover, IKKα null macrophages treated with lipotoxic palmitic acid exhibited early exhaustion of Akt signaling compared with wild-type cells. This was accompanied by a dramatic decrease in the resistance of IKKα −/− monocytes and macrophages to different proapoptotic stimuli compared with wild-type cells. In vivo, IKKα deficiency increased macrophage apoptosis in atherosclerotic lesions and decreased early atherosclerosis in both female and male low-density lipoprotein receptor (LDLR) −/− mice reconstituted with IKKα −/− hematopoietic cells and fed with the Western diet for 8 weeks compared with control LDLR −/− mice transplanted with wild-type cells.
A therosclerosis is a progressive inflammatory disease and the underlying cause of heart attack and stroke. 1 Macrophage-derived foam cells are the major cell type in early atherosclerotic lesions and a key feature of unstable plaques. 2 The ability of macrophages to survive in atherosclerotic lesions is an important modulator of atherosclerotic lesion development. 3 For example, increased sensitivity of macrophages to apoptosis suppresses early lesion progression, whereas in advanced lesions, macrophage apoptosis promotes necrotic core formation, increasing plaque vulnerability and thrombosis. 4 Two major signaling pathways, PI3K/Akt and nuclear factor κB (NF-κB), regulate cell survival. 5, 6 However, the impact of these pathways on macrophage survival and atherosclerosis remains unclear.
NF-κB activation relies on inducible degradation of IκBα, which is mediated through its phosphorylation by the IκB kinase (IKK), a complex consisting of 2 catalytic subunits, IKKα and IKKβ, and a regulatory subunit, IKKγ. IKKβ initiates the well-defined classical NF-κB pathway, whereas IKKα has been implicated in the alternative pathway. 7 IKKα plays a key role in the negative feedback of NF-κB signaling to limit inflammatory gene activation in macrophages. 8, 9 In addition, IKKα is also required for B-cell maturation and formation of secondary lymphoid organs. 10 IKKα −/− mice die soon after birth because of dramatic abnormalities in morphogenesis. 11, 12 IKKβ knockout mice die as embryos (day F13), primarily due massive hepatocyte apoptosis. 13, 14 Furthermore, IKKα/ IKKβ double-knockout mice die at E12 because of enhanced apoptosis of the fetal liver during neurulation. 15 These data indicate that IKKα and IKKβ are essential for NF-κB activation, which plays a crucial role in protecting against excessive apoptosis. The results also suggest a possible link between the IKK pathway and the PI3K/Akt pathway, which is well known for its antiapoptotic action.
Human and mouse macrophages express constitutively active p-Akt, which is vital for their survival 16 and inhibition of PI3K or Akt induces apoptosis. 17 IKKα is known as a target in antiapoptotic signaling of the PI3K/Akt pathway. [18] [19] [20] Recent reports indicate that IKKα directly regulates Akt signaling acting at several different levels and mediates cross talk between the Akt and NF-κB pathways. [21] [22] [23] [24] For example, both IKKα and IKKβ phosphorylate p85α promoting feedback inhibition of PI3K/Akt signaling in response to cellular starvation. 21 IKKα is also required for the mammalian target of rapamycin (mTOR) activity, 22 which forms 2 functionally distinct complexes: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The mTORC1 is a nutrient/energy/redox sensor consisting of mTOR, regulatory associated protein of mTOR (Raptor), mammalian lethal with SEC13 protein 8, and Deptor, a negative regulator of mTOR. In contrast, mTORC2 controls activity of an important phosphorylation site for Akt signaling, Akt S 473 , and cell survival. 25 mTORC2 consists of mTOR, rapamycin-insensitive companion of mTOR (Rictor), stressactivated protein kinase-interacting protein (Sin1), mammalian lethal with SEC13 protein 8, and Protor. IKKα directly phosphorylates mTOR to drive mTORC1 activation 23 and interacts with rictor to regulate the function of mTORC2. 24 These data suggest a complex regulation of Akt signaling by IKKα.
Recently, Tilstam et al 26 have shown that hematopoietic knock-in of a nonactivatable IKKα kinase mutant, in which the activation loop serines were replaced with alanines (Ikkα AA/AA ), in apolipoprotein E (ApoE) −/− mice had no effect on atherosclerosis. However, it is important to note that Ikkα AA/AA mice had no changes in IKKα activity and did not exhibit morphological defects, which are specific for IKKα loss. 27 Therefore, the impact of complete loss of IKKα protein and activity in hematopoietic cells on atherogenesis remains to be examined.
In this study, we found that loss of IKKα in macrophages significantly suppresses Akt S 473 phosphorylation and this compromises cell survival. In addition, we show that IKKα deficiency in hematopoietic cells increases macrophage apoptosis and reduces atherosclerosis in vivo. Our data reveal a novel mechanism by which IKKα controls Akt signaling and macrophage survival with important implications in atherogenesis.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement. Loss of IKKα in macrophages suppresses Akt signaling, reduces cell viability, and early atherosclerosis.
Results

IKKα Deficiency in Mouse Macrophages Inhibits Akt S 473 Phosphorylation
Recent studies reported that IKKα regulates Akt signaling acting at several different levels of the pathway. [21] [22] [23] Therefore, we analyzed whether loss of IKKα affects Akt signaling in mouse macrophages. Because IKKα −/− mice die soon after birth because of dramatic abnormalities in morphogenesis. 11, 12 We used a fetal liver cell transplantation approach 28 to generate C57BL/6 mice with IKKα −/− or wild-type (WT or IKKα +/+ ) macrophages to study Akt signaling.
First, we examined whether loss of macrophage IKKα affects Akt activation in vitro. We found that recombinant mouse platelet-derived growth factor induced phosphorylation of p-Akt S 473 in WT type (≈2-fold increase), but not in IKKα −/− cells, whereas the content of Akt and β-actin remained comparable ( Figure 1A and 1B). Similarly, IKKα −/− macrophages exhibited decreased levels of Akt S 473 phosphorylation in response to insulin or Akt activator, SC79 ( Figure IA -ID in the online-only Data Supplement). These results indicate that Akt S 473 phosphorylation is impaired in IKKα −/− macrophages.
Next, we tested whether pharmacological IKK inhibition affects Akt signaling in macrophages. Treatment of WT macrophages with a specific IKK inhibitor, Bay 11-7082, suppressed the levels of p-Akt S 473 in a dose-and time-dependent manner ( Figure 1C and 1D). Thus, both genetic deficiency of IKKα and pharmacological inhibition of IKK suppress Akt phosphorylation in macrophages.
Because Akt S 473 activity is regulated by mTORC2, 29 we examined whether IKKα plays an important role in mTORC2mediated Akt signaling of mouse macrophages. First, we studied its downstream targets, including serum-and glucocorticoid-induced protein kinase-1 (SGK1) and protein kinase Cα (PKCα). The protein levels of both of these downstream targets were significantly lower in IKKα −/− macrophages treated with insulin (36% p-SGK1 and 72% p-PKCα) than in WT cells ( Figure 1E ). It is known that prolonged rapamycin treatment inhibits the assembly of mTORC2 in different types of cells. 30 Here, we demonstrate that WT macrophages treated with rapamycin overnight exhibited significant suppression of the mTORC2 targets, p-SGK1 (38%) and p-protein kinase Cαα (67%), compared with untreated cells ( Figure 1F ). These results indicate that mTORC2 signaling is suppressed in IKKα −/− macrophages, and a similar effect can be induced in WT cells by inhibiting the assembly of mTORC2.
Finally, to analyze mTOR complexes in WT and IKKα −/− macrophages, we used an antibody to mTOR to precipitate the complexes. The precipitates contained the major components of the mTORC, including mTOR, Raptor and Rictor ( Figure 1G) . Surprisingly, IKKα was also present in the precipitates from WT macrophages ( Figure 1G ). Remarkably, mTORC2 precipitated by an antibody to Rictor also contained IKKα ( Figure 1H ). Therefore, we examined whether an antibody to IKKα is capable of precipitating mTORC2 compared with an isotype control and Rictor. The precipitates formed by the antibody to IKKα or Rictor, but not the isotype control, contained mTOR and Rictor ( Figure 1I ). Importantly, the precipitates also exhibited Akt kinase activity specific for mTORC2 ( Figure 1I , bottom). In contrast, loss of IKKα in macrophages prevents the precipitation of mTORC2 by the antibody to IKKα ( Figure  II in the online-only Data Supplement). These results indicate that IKKα plays an important role in mTORC2-mediated Akt signaling of mouse macrophages.
IKKα −/− Macrophages Have Increased Sensitivity to Proapoptotic Stimuli and Express High Levels of Inflammatory Genes in Response to Lipopolysaccharides
Because Akt signaling is the major prosurvival pathway that suppresses apoptosis, 5 we suspected that defective phosphorylation of Akt S 473 in IKKα −/− macrophages may compromise cell survival. In addition, a recent report 31 has demonstrated that endoplasmic reticulum stress inhibits mTORC2 activity and Akt signaling. Therefore, we hypothesized that IKKα −/− macrophages may be less resistant to endoplasmic reticulum stress conditions than WT cells. To test this hypothesis, WT and IKKα −/− peritoneal macrophages were treated with palmitic acid (PA), a lipotoxic factor that induces endoplasmic reticulum stress and triggers apoptosis. 32 Compared with WT cells, IKKα −/− macrophages had early exhaustion of Akt signaling, with suppression of p-AktS 473 (Figure 2A and 2B) and p-Bad 136 ( Figure III in the online-only Data Supplement). The treatment with PA significantly increased the number of terminal deoxynucleotidyl tranferase dUTP nick end labeling (TUNEL)-positive nuclei in both cell types ( Figure 2C-2F ), but IKKα −/− macrophages had significantly higher levels of apoptosis than WT macrophages ( Figure 2G ). In addition, substantially more IKKα −/− macrophages underwent apoptotic changes when treated with oxidized-lowdensity lipoprotein (80%) or acetylated-LDL (63%) together with an ACAT (Acyl-CoA:cholesterol acyltransferase) inhibitor, Sandoz 58035, than did WT cells ( Figure 2H ). Compared with WT cells, IKKα −/− cells were predisposed to apoptosis (117%) in response to a specific inhibitor of IkBα phosphorylation, BAY 11-7082 ( Figure 2I ). Interestingly, treatment with wedelolactone (Wede), an inhibitor of IKK, alone had only a slight effect on apoptosis in both cell types, whereas the combination of Wede and PA significantly increased apoptosis in WT and IKKα −/− macrophages ( Figure 2J ), indicating the importance of Akt activity in the stress response mechanism. In contrast, the constitutively activated p-Akt in PTEN −/− macrophages significantly increased resistance to PA-induced stress ( Figure IVA and IVB in the online-only Data Supplement) and protected the cells from apoptosis compared with WT macrophages ( Figure IVC and IVD in the online-only Data Supplement). Taken together, these data support the concept that suppression of Akt signaling in IKKα −/− macrophages generates a cell phenotype with enhanced sensitivity to apoptosis. In addition, WT and IKKα −/− peritoneal macrophages were treated with lipopolysaccharides, and the levels of inflammatory genes were measured by real-time polymerase chain reaction. Compared with WT cells, IKKα −/− macrophages showed increased expression of proinflammatory genes including Il1b, Il6, and Il12a ( Figure 3A-3C ). In contrast, the levels of Il10 gene expression was significantly lower in IKKα −/− macrophages than in WT cells ( Figure 3D ). These results indicate that IKKα −/− macrophages express higher levels of inflammatory genes but low levels of the Il10 gene, representing the classical proinflammatory M1 phenotype.
Hematopoietic IKKα Deficiency Changes Blood Cells Decreasing Monocyte Viability and Decreasing Early Atherosclerosis
To examine if macrophage IKKα deficiency has an impact on atherosclerosis in vivo, we conducted 2 separate experiments in female and male recipients because of the established impact of sex on atherosclerosis in mice. In the first experiment, 8-week-old female LDL-receptor (LDLR) −/− mice were lethally irradiated and transplanted with female IKKα +/+ (control group; n=11) or IKKα −/− (n=10) fetal liver cell. After 4 weeks of the chow diet, the ratio of blood leukocytes was determined in recipient mice by flow cytometry. Compared with control WT→WT mice, IKKα −/− →WT mice had a dramatic decrease in blood B cells and lower numbers of T cells Cells were incubated in serum-free media for 16 hours and then treated with PDGF (20 ng/mL) for 0 (control), 10, 15, and 20 minutes. Proteins were extracted, resolved (60 μg/well) and analyzed by Western blot using antibodies against the proteins indicated. Graphs represent data (mean±SEM) of 3 experiments (*P<0.05 compared with control untreated group). (C and D, An IKK inhibitor, Bay 11-7082, suppresses Akt S 473 signaling in a dose-and time-dependent manner. WT peritoneal macrophages were treated with 0 to 100 μmol/L Bay 11-7082 for 30 minutes (C) or with 40 μmol/L Bay 11-7082 for 0 to 120 minutes (D). Then proteins were extracted and subjected to Western blot analysis using antibodies to p-Akt (S 473 ) and β-actin. E and F, mTORC2 targets, serum-and glucocorticoid-induced protein kinase-1 (SGK1) and protein kinase Cα (PKCα) are suppressed in IKKα −/− macrophages and similar suppression is exhibited by WT macrophages treated with rapamycin overnight. WT and IKKα −/− macrophages were cultured in serum-free media alone (E) or with rapamycin (100 nmol/L; F) for 16 hours and then treated with insulin (100 nmol/L) for 10 or 20 minutes. Extracted proteins were analyzed using antibodies to p-SGK (Ser 422 ) and p-PKCα (Ser 657 ). G-I, IKKα in cell precipitates formed by the antibody to mTOR (G), Rictor (H) or IKKα (I) from WT and IKKα −/− macrophage lysates. Note the presence of IKKα in mTOR complexes (G) and mTORC2 (H). I, Top, Comparison of different antibodies including isotype control (1), antibody to Rictor (2), or antibody to IKKα (3); and (Bottom) kinase assays performed with precipitates from WT macrophages, antibodies to p-Akt (S 473, ) and in the presence of full-length Akt1 protein as the substrate.
( Figure 3E and 3F) . In contrast, numbers of neutrophils and monocytes were increased ( Figure 3G and 3H) , including both Ly-6C hi and Ly-6C lo subsets ( Figure 3I and 3J) . These blood cell changes were accompanied by enlargement of the spleen (0.11+0.01 versus 0.08+0.01 g; P=0.01) and altered spleen histology ( Figure V in the online-only Data Supplement). In addition, IKKα −/− →WT mice had high levels of apoptosis in blood cells with no differences in neutrophils but with increased monocyte apoptosis ( Figure 4A-4C ). To further investigate this phenomenon, we isolated blood monocytes and treated them with PA-bovine serum albumin overnight. Analysis of apoptosis by Annexin V stain demonstrated that IKKα −/− monocytes had significantly increased apoptosis compared with WT cells (Figure 4D and 4E) . Thus, IKKα −/− monocytes exhibit compromised resistance to apoptotic stimuli compared with WT cells.
After 8 weeks on the Western diet, no significant differences in body weight, serum total cholesterol, and triglyceride levels were found between groups ( Table  I in the online-only Data Supplement). Remarkably, IKKα −/− →LDLR −/− mice had a 63.3% smaller atherosclerotic lesion area in the proximal aorta than mice transplanted with WT cells (Figure 5A -5F, and 5I; 98±15 versus 269±25×10 3 μm 2 ; P=0.040). Similarly, IKKα −/− →LDLR −/− mice had smaller atherosclerotic lesions in pinned out aortas compared with mice transplanted with WT fetal liver cell ( Figure 5G , 5H, and 5J; 2.1±0.4 versus 1.1±0.2%; P=0.023).
The IKKα −/− →LDLR −/− mice also had significantly reduced MOMA-2-positive area in their atherosclerotic lesions compared with WT→LDLR −/− mice ( Figure 5K ). Importantly, IKKα −/− →LDLR −/− mice had significantly more TUNELpositive cells in their atherosclerotic lesions than control WT→LDLR −/− mice ( Figure 5L ). Next, we examined impact of loss IKKα on macrophage apoptosis and proliferation in the atherosclerotic lesions. Double staining of sections from the aortic sinus with the antibody to macrophage, MOMA-2, and anticleaved caspase 3 verified that these apoptotic cells are macrophage in origin ( Figure VI In a second experiment designed to exclude a sexrelated difference in atherosclerosis, 33 8-week-old male LDLR −/− mice were lethally irradiated and transplanted with IKKα +/+ (control group; n=7) or IKKα −/− (n=9) fetal liver cell. Again, there were no statistically significant differences in body weight and serum lipid levels ( Table I in the online-only Data Supplement). These male recipients had smaller (45.6%) atherosclerotic lesions than control male WT→LDLR −/− mice ( Figure 6A -6F, and 6I; 91±44 versus 167±75×10 3 μm 2 ; P=0.001). Compared with control WT→LDLR −/− mice, IKKα −/− →LDLR −/− mice also had significantly reduced atherosclerotic lesions in pinned out aortas ( Figure 6G , 6H, and 6J; 0.29±0.02 versus 0.37±0.03%; P=0.014), less MOMA-2-positive area ( Figure 6K) , and more TUNEL-positive cells in the atherosclerotic lesion area ( Figure 6L ). These results demonstrate that elimination of IKKα in hematopoietic cells significantly increases macrophage apoptosis in atherosclerotic lesions and diminishes atherosclerosis in mice of both sexes.
Discussion
Macrophages are uniquely resistant to proapoptotic stimuli and the ability of macrophages to survive is a key determinant of the development of atherosclerotic lesions. IKKα is associated with 2 prosurvival pathways, the PI3K/Akt and NF-κB, but its role in macrophage survival and atherosclerosis remains unclear. Here, we demonstrate that IKKα deficiency in mouse macrophages significantly suppresses Akt phosphorylation and this radically compromises cell resistance to proapoptotic stimuli. Furthermore, our results show that IKKα plays a crucial role in mTORC2-mediated Akt signaling in macrophages. We also provide in vivo evidence that male and female LDLR −/− mice reconstituted with IKKα −/− hematopoietic cells have smaller atherosclerotic lesions that are enriched in apoptotic macrophages compared with control mice transplanted with WT cells. Thus, IKKα plays an important role in Akt phosphorylation and IKKα deficiency reduces macrophage survival and suppresses early atherosclerosis. NF-κB inducing kinase acting through IKKα triggers the alternative NF-κB pathway, which is crucial for the generation of B and T lymphocytes and the development of lymphoid organs. 34 In addition, IKKα limits the NF-κBmediated expression of inflammatory genes in macrophages, and macrophage IKKα deficiency enhances inflammation. 8, 9 Our results are consistent with this role for IKKα in that IKKα −/− →LDLR −/− mice exhibited monocytosis and more Ly-6C hi monocytes and M1 macrophages. However, loss of IKKα also powerfully suppressed antiapoptotic Akt signaling in both blood monocytes and macrophages, dramatically decreasing their viability compared with control WT cells. Because macrophages play a key role in atherosclerotic lesion formation, 2 the compromised ability of IKKα −/− monocytes/macrophages to survive markedly modulates atherogenesis diminishing early lesion development. Thus, we think that the suppression of Akt because of loss of IKKα increases macrophage apoptosis, playing a dominant role in reducing atherosclerosis.
In addition, we found decreased numbers of T cells in blood of IKKα −/− →LDLR −/− mice and these data support the view that IKKα is an essential component of T-cell regulatory function. 35 Finally, our IKKα −/− →LDLR −/− mice had significantly diminished numbers of blood B cells and this is in harmony with the notion that IKKα is essential for B-cell maturation. 10 A similar B-cell reduction was described in kinase-dead IKKα knock-in mice. 36 Importantly, loss of B cells has been reported to both increase 37, 38 and decrease 39 the extent of atherosclerosis. More recent studies suggest that traditional T cell-driven B2 cell responses seem to be atherogenic, whereas innate B1 cells seem to exert a protective action via the secretion of naturally occurring antibodies. 40 Therefore, it is uncertain whether the decreased numbers of T or B cells because of IKKα deficiency affected the development of atherosclerosis, and future studies will be required to address this issue.
Our data implicating mTORC2 assembly in IKKαmediated Akt signaling are consistent with a recent study 24 reporting that Rictor directly interacts with both IKKα and IKKβ. Chemical inhibition of IKK, knockdown of IKK by siRNA, or expression of kinase-dead IKK significantly inhibited the kinase activity of mTORC2 suppressing Akt S 473 phosphorylation. 24 At present, the precise sites of IKKαmediated phosphorylation are unknown. IKKα likely interacts with mTORC2 essential components, Rictor and Sin1, which form a heterodimer that determines the mutual stability of both proteins. 41 Rictor contains 21 unique phosphorylation sites clustered in the C-terminal end, and this sequence is highly conserved among vertebrates. 42 Phosphorylation of Sin1, triggered by several different growth factors, suppresses mTORC2 kinase activity by dissociating Sin1 from the complex. 43 Taken together, our results strongly indicate that IKKα regulates Akt signaling in macrophages, and this suggests an exciting opportunity to target this pathway to affect function of the innate immune system cells, which are critically involved in a variety of pathological processes.
It is important to note that assembly of mTORC2 is a complex process, and its impairment results in suppression of Akt S 473 activity. For example, both Rictor and mammalian lethal with SEC13 protein 8 are required for Akt signaling, and genetic deletion of either of them is associated with complete loss of Akt S 473 activity. 44 Similarly, genetic ablation of another key component of mTORC2, Sin1, eliminated Akt S 473 phosphorylation, whereas T 308 activity was preserved. 41, 45, 46 Even a single Rictor point mutation (G934E) markedly reduced Akt S 473 phosphorylation. 47 Importantly, loss of Sin1 and consequently p-Akt S 473 significantly increased cell susceptibility to stress-induced apoptosis 41 supporting the concept that Akt signaling is antiapoptotic. Thus, our current results provide experimental support for this concept by demonstrating that loss of IKKα reduces Akt activity in macrophages, increasing their sensitivity to apoptosis.
The current results also demonstrate that deficiency of IKKα in hematopoietic cells reduces early atherosclerosis in vivo. The atherosclerotic lesions of IKKα −/− →LDLR −/− mice had dramatically increased macrophage apoptosis and reduced macrophage area compared with lesions of IKKα +/+ →LDLR −/− mice. These data are consistent with the report 48 demonstrating that Akt S 473 phosphorylation was markedly reduced in macrophages lacking the PI3-kinase 110γ, and this significantly diminished atherosclerosis in apoE −/− mice. In contrast, Tilstam et al 26 have shown recently that apoE −/− mice reconstituted with IKKα knock-in (Ikkα AA/AA ) bone marrow cells had less B and T cells but no differences in atherosclerosis compared with control mice transplanted with apoE −/− marrow. Importantly, Ikkα AA/AA bone marrow-derived macrophages did not exhibit changes in NF-κB activity or cytokine expression. 26 These results are consistent with the initial report 27 indicating that Ikkα AA/AA mice do not exhibit morphological defects specific for loss of IKKα 11, 12 with the only exception being that females displayed a severe lactation defect due impaired proliferation of mammary epithelial cells. Similar to macrophages, Ikkα AA/AA embryonic fibroblast did not show any changes in IKK or NF-κB activation induced by tumor necrosis factor-α, interleukin (IL)-1, or endotoxin. 27 Thus, Ikkα AA/AA cells presumably have preserved IKKα kinase activity, which likely underlies the difference in our results about the role of IKKα in atherosclerosis. In contrast, we report that genetic ablation of IKKα in the bone marrow, which results in complete loss of IKKα protein and activity in hematopoietic cells, dramatically reduces atherosclerosis in LDLR −/− mice, demonstrating a crucial role for expression of IKKα in hematopoietic cells in atherogenesis.
In conclusion, our data demonstrate that loss of IKKα in macrophages suppresses mTORC2-mediated Akt S 473 signaling and this compromises cell survival and decreases early atherosclerosis ( Figure VIII in the online-only Data Supplement). These results support an inverse relationship between macrophage apoptosis and lesion size in early atherosclerotic lesions. 4 Our findings also stress a crucial role of IKKα in mTORC2-mediated Akt signaling and provide new therapeutic targets for the regulation of macrophage survival and the prevention of atherosclerosis. 
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